Fulcrum Therapeutics (FULC) Depreciation and Depletion (2019 - 2026)

Fulcrum Therapeutics (FULC) has disclosed Depreciation and Depletion for 7 consecutive years, with $400000.0 as the latest value for Q4 2025.

  • Quarterly Depreciation and Depletion changed 0.0% to $400000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.4 million through Dec 2025, down 17.65% year-over-year, with the annual reading at $1.4 million for FY2025, 12.5% down from the prior year.
  • Depreciation and Depletion for Q4 2025 was $400000.0 at Fulcrum Therapeutics, up from $300000.0 in the prior quarter.
  • The five-year high for Depreciation and Depletion was $700000.0 in Q2 2021, with the low at $300000.0 in Q2 2025.
  • Average Depreciation and Depletion over 5 years is $511150.0, with a median of $518000.0 recorded in 2022.
  • The sharpest move saw Depreciation and Depletion increased 20.0% in 2021, then plummeted 33.33% in 2024.
  • Over 5 years, Depreciation and Depletion stood at $621000.0 in 2021, then dropped by 3.38% to $600000.0 in 2022, then decreased by 10.67% to $536000.0 in 2023, then dropped by 25.37% to $400000.0 in 2024, then changed by 0.0% to $400000.0 in 2025.
  • According to Business Quant data, Depreciation and Depletion over the past three periods came in at $400000.0, $300000.0, and $300000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.